alpha-cyano-4-hydroxycinnamate has been researched along with Dementia in 1 studies
alpha-cyano-4-hydroxycinnamate: specific inhibitor of pyruvate transport in rat liver mitochondria & human erythrocytes; structure
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ruegsegger, GN | 1 |
| Manjunatha, S | 1 |
| Summer, P | 1 |
| Gopala, S | 1 |
| Zabeilski, P | 1 |
| Dasari, S | 1 |
| Vanderboom, PM | 1 |
| Lanza, IR | 1 |
| Klaus, KA | 1 |
| Nair, KS | 1 |
1 other study available for alpha-cyano-4-hydroxycinnamate and Dementia
| Article | Year |
|---|---|
Insulin deficiency and intranasal insulin alter brain mitochondrial function: a potential factor for dementia in diabetes.
Topics: Adenosine Triphosphate; Administration, Intranasal; Animals; Brain; Coumaric Acids; Dementia; Diabet | 2019 |